Levofloxacin Min 99% API CAS NO.100986-85-4

MSDS/COA Download
Min.Order: 1 Gram
Payment Terms: L/C,T/T

Product Details

Keywords

LVFX
Levaquin
Levofloxacin

Quick Details

ProName: Levofloxacin Min 99% API
CasNo: 100986-85-4
Molecular Formula: C18H20FN3O4
Appearance: White powder
Application: API, antibiotic.Mainly used in the man...
DeliveryTime: 3 days
PackAge: 25 KG/Drum
Port: Tianjin/ Shanghai /Qingdao
ProductionCapacity: 200 Metric Ton/Day
Purity: Min 99%
Storage: Dry place in sealed container.
Transportation: According to the customer
LimitNum: 1 Gram
Grade: Pharma Grade
Assay: >=99.0% (99.40%)
Heavy Metals: <=0.002%
Residue on ignition: <=0.2%(0.03%)
Limit of (r)-olfx: <=1.0%(0.26%)
Loss on drying: <=3.0%(2.40%)
HPLC Individual impurity: <=0.1%(0.08%)

Superiority

1.Competitive price with high quality material along with proper and complete documents;

2.Your stable supply channel for your choice; Earliest delivery time ;

3.Supply full range of APIs & Chemicals to reduce your many varieties of purchasing cost;

4.Timely ,possitive communication

Details

Company Profile:

Company Name:Jiaozuo Wanying Trade Co. Ltd.

Year Established: 2005

Main products:APIs including Amoxicllin,Norfloxacin,Levofloxacin,Analgin,Diclofenac sodium,Oxytetracycline,Metronidazole,Ibprophan,and others as showed in the following product list.

Introduction

Levofloxacin

CAS No.: 100986-85-4

MF: C₁₈H₂₀FN₃O₂

MW.: 361.37

Purity:Min 98%

Appearance: White powder

Packing: 25 KG/Drum

COA

Usage

1)Mainly used in the manufacture of all kinds of ofloxacin capsules, tablets and other antibacterial agents;

2)For the whole synthetic antimicrobial, used in the treatment of respiratory tract, urinary tract and skin tissue infection, etc;

3)Levofloxacin has excellent activity in vitro, than ofloxacin side effects, safety, large and small good pharmacokinetic properties. Can be widely used in respiratory tract infection, infection of gynecological diseases, skin and soft tissue infection, surgical infection, biliary infection, infection and other sexually transmitted diseases and ear nose dental bacterial infection of an oral or intestines and stomach for external use of broad-spectrum fluoroquinolone antibacterial drugs.